Tech Company Financing Transactions
Pulmokine Funding Round
On 3/5/2015, Pulmokine landed $1 million in funding from Broadview Ventures.
Transaction Overview
Company Name
Announced On
3/5/2015
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7 University Pl. B127
Rensselaer, NY 12144
USA
Rensselaer, NY 12144
USA
Phone
Website
Email Address
Overview
Pulmokine is a privately held biopharmaceutical company. Our focus is on pulmonary disease and kinase inhibitor technology, hence our name Pulmokine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Shreefal Mehta
Chief Executive Officer
Larry Zisman
VP - Regulatory Affairs
Ron Wolff
Browse more venture capital transactions:
Prev: 3/5/2015: Namely venture capital transaction
Next: 3/5/2015: ViewRay venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs